Printed on recycled paper131st MAINE LEGISLATURE
FIRST REGULAR SESSION-2023
Legislative Document No. 242
S.P. 108 In Senate, January 20, 2023
An Act to Clarify That Animal Health Products Are Exempt from 
the Perfluoroalkyl and Polyfluoroalkyl Substances Reporting Law
Reference to the Committee on Environment and Natural Resources suggested and ordered 
printed.
DAREK M. GRANT
Secretary of the Senate
Presented by Senator BALDACCI of Penobscot.

Page 1 - 131LR1344(01)1Be it enacted by the People of the State of Maine as follows:
2Sec. 1.  38 MRSA §1614, sub-§4, as enacted by PL 2021, c. 477, §1 and reallocated 
3 by RR 2021, c. 1, Pt. A, §54, is amended to read:
44.  Exemptions.  The following are exempt from this section:
5 A.  A product for which federal law governs the presence of PFAS in the product in a 
6 manner that preempts state authority; and
7 B.  A product subject to Title 32, chapter 26‑A or 26‑B. ; and
8 C.  A product intended for animals that is regulated as an animal drug, biologic or 
9 parasiticide administered to animals or a medical device or diagnostic used to treat 
10 animals under the Federal Food, Drug, and Cosmetic Act, as in effect on January 1, 
11 2023; the federal Virus-Serum-Toxin Act, as in effect on January 1, 2023; or the 
12 Federal Insecticide, Fungicide, and Rodenticide Act, as in effect on January 1, 2023.
13SUMMARY
14 This bill provides that certain health products intended for animals that are regulated 
15 under the Federal Food, Drug, and Cosmetic Act, the federal Virus-Serum-Toxin Act or 
16 the Federal Insecticide, Fungicide, and Rodenticide Act are exempt from the notification 
17 requirements that generally apply to products containing perfluoroalkyl and 
18 polyfluoroalkyl substances.14
15
16
17
18
